- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03626805
Muscle Tenderness and Hardness in Migraine Patients
Study Overview
Status
Detailed Description
Migraine patients exhibit different symptomatology and responses to treatment. For example do many migraine patients have neck symptoms, despite they apparently do not have any neck disorders.Furthermore the response to treatment differs between patients. Differences in symptomatology, QST parameters and muscle stiffness can be used to subdivide and phenotype migraine patients.
The investigators are examining migraine patients with:
A semistructured interview, Quantitative sensory testing (cold pain threshold, heat pain threshold and Pin Prick), Muscle tenderness (total tenderness score, local tenderness score and stimulus response curve), and muscle hardness with ultrasound elastography. All tests are performed the same day
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Glostrup, Denmark, 2600
- Danish Headache Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Migraine patients are recruited from the out-patient clinic at the Danish Headache Center.
Healthy controls are recruited through web-sites.
Description
Inclusion Criteria:
- Migraine Patients from the Danish Headache Centre. Migraine classified using the International Classification of Headache Disorders (ICHD3) criteria.
Exclusion Criteria:
- Pregnant or lactating women
- Musculoskeletal injuries in the neck or shoulder
- Other primary headache disorders than migraine or Tension Type Headache
- On the time of examination: Migraine free for at least 48 hours
- On the time of examination: haven't trained the upper body for at least 48 hours
- On the time of examination: haven't used painkillers for at least 48 hours
Healthy controls:
Exclusion Criteria:
- Pregnant or lactating women
- Musculoskeletal injuries in the neck or shoulder
- Migraine disorders
- 1. degree relatives with migraine disorders
- Over 1 day of tension type headache a month.
- On the time of examination: haven't trained the upper body for at least 48 hours
- On the time of examination: haven't used painkillers for at least 48 hours
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
---|
Migraine patients
Migraine patients attending the Danish Headache Centre
|
Healthy Controls
Age and sex matched
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Logistic regression model, Neck Stiffness
Time Frame: 3 hours
|
We would like to examine the relationship between the variable variable: Neck stiffness during migraine attack (Yes/No) and the Independent variables: Total Tenderness Score (summed score from 8 points bilateral, each point can score 0-3), Migraine localisation (occipital: Yes/No), Tension Type Headache, Allodynia (yes/No), Stimulus response curve (Pressure and Pain). The result shows how much of the variability in neck stiffness that can be explained by the independent variables. |
3 hours
|
Pericranial Muscle Tenderness
Time Frame: 3 hours
|
We will examine whether patients with neck stiffness during migraine attack (yes/no) have higher tenderness scores compared to patients without neck stiffness during migraine attacks, when correcting for headache frequency.
|
3 hours
|
Muscle Hardness measured by ultrasound elastography
Time Frame: 3 hours
|
Muscle hardness (m/s) in migraine patients compared to healthy controls.corrected
for age, BMI and sex
|
3 hours
|
Muscle hardness measured by ultrasound elastography in migaine patients
Time Frame: 3 hours
|
Muscle hardness (m/s) in migraine patients with neck stiffness during migraine attacks compared to migraine patients without neck stiffness during migraine attacks.
Corrected for age, BMI and sex.
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Multiple Regression model, Total Tenderness Score
Time Frame: 3 hours
|
We would like to examine the relationship between the dependent variable: Total Tenderness Score(summed score from 8 points bilateral, each point can score 0-3), and the Independent variables: Neck Pain in general(Yes/No), Migraine localisation (occipital: Yes/No), Headache Frequency(days/month), Allodynia (Yes/No), Years with Migraine(Number of years)
|
3 hours
|
Logistic regression model, Neck pain in general
Time Frame: 3 hours
|
We would like to examine the relationship between the variable variable: Neck pain in general (Yes/No) and the independent variables: Tension Type Headache(yes/no), Migraine localisation, Headache Frequency(Headache days/month), Allodynia(yes/No), Years with Migraine(number of years)
|
3 hours
|
Next migraine attack, Cox proportional hazards model
Time Frame: 3 hours
|
Using the prospective diary, we will examine the relationship between pericranial muscle tenderness and the next migraine attack, when correcting for headache frequency
|
3 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation analysis of muscle hardness and headache frequency
Time Frame: 3 hours
|
Muscle hardness will be measured with ultrasound elastography.
Headache frequency is self-reported
|
3 hours
|
Correlation analysis of muscle hardness and muscle tenderness assessed with the total tenderness score.
Time Frame: 3 hours
|
Muscle hardness will be measured with ultrasound elastography.
|
3 hours
|
Correlation analysis of muscle hardness and pressure pain threshold assessed with an pressure algometer.
Time Frame: 3 hours
|
Muscle hardness will be measured with ultrasound elastography
|
3 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jeppe H Mann, MD, Danish Headache Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Diseases
- Musculoskeletal Pain
- Myalgia
- Disease
- Nervous System Diseases
- Migraine Disorders
- Headache
- Headache Disorders
- Headache Disorders, Primary
Other Study ID Numbers
- 001 (NavyGHB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nervous System Diseases
-
Bracco Diagnostics, IncCompletedCentral Nervous System Neoplasms | Central Nervous System Disease
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingCentral Nervous System TumorUnited States
-
University of MichiganCompletedAutonomic Peripheral Nervous System DiseasesUnited States
-
Washington University School of MedicineRecruitingCentral Nervous SystemUnited States
-
European Organisation for Research and Treatment...Merck Sharp & Dohme LLC; Medical Research Council; NCIC Clinical Trials Group; Radiation...Active, not recruitingBrain and Central Nervous System TumorsNetherlands, United Kingdom, Australia, United States, Belgium, France, Germany, Canada, Israel, Switzerland, Italy, Spain
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Children's Hospital Medical Center, CincinnatiNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States